Cohort characteristics
| . | . | . |
|---|---|---|
| CyTOF cohort | Non-allergic | AR |
| Number of subjects | 14 (1 WD) | 14 (4 WD) |
| Female (%) | 64.3 | 46.7 |
| Median age (min-max) | 23 (18–49) | 26 (18–45) |
| Median SPT | Negative (<0.4) | 1.01 (0.47–3.47) |
| Median HDM-specific serum IgE (CAPFEIA) | Negative (<0.35 KU/I) | 12.7 (0.39- >100) |
| Median symptom score | Negative (<5) | 18 (11–28) |
| Co-sensitizations (median) | 0 | 2.5 |
| Birch pollen (%) | 0 | 68.75 |
| Grass pollen (%) | 0 | 68.75 |
| Cat (%) | 0 | 56.25 |
| Dog (%) | 0 | 50 |
| scRNA-Seq cohort | Non-allergic | AR |
| Number of subjects | 18 | 21 |
| Female (%) | 61.1 | 52.4 |
| Median age (min-max) | 25 (19–49) | 24 (18–45) |
| Median SPT | Negative (<0.4) | 1.01 (0.46–2.48 |
| Median HDM-specific serum IgE (CAPFEIA) | Negative (<0.35 KU/I) | 8.9 (0.39–>100) |
| Median symptom score | Negative (<5) | 18 (9–28) |
| Co-sensitizations (median) | 0 | 3 |
| Birch pollen (%) | 0 | 75 |
| Grass pollen (%) | 0 | 81.25 |
| Cat (%) | 0 | 43.75 |
| Dog (%) | 0 | 56.25 |
| Cohort overlap | 12 | 12 |
| . | . | . |
|---|---|---|
| CyTOF cohort | Non-allergic | AR |
| Number of subjects | 14 (1 WD) | 14 (4 WD) |
| Female (%) | 64.3 | 46.7 |
| Median age (min-max) | 23 (18–49) | 26 (18–45) |
| Median SPT | Negative (<0.4) | 1.01 (0.47–3.47) |
| Median HDM-specific serum IgE (CAPFEIA) | Negative (<0.35 KU/I) | 12.7 (0.39- >100) |
| Median symptom score | Negative (<5) | 18 (11–28) |
| Co-sensitizations (median) | 0 | 2.5 |
| Birch pollen (%) | 0 | 68.75 |
| Grass pollen (%) | 0 | 68.75 |
| Cat (%) | 0 | 56.25 |
| Dog (%) | 0 | 50 |
| scRNA-Seq cohort | Non-allergic | AR |
| Number of subjects | 18 | 21 |
| Female (%) | 61.1 | 52.4 |
| Median age (min-max) | 25 (19–49) | 24 (18–45) |
| Median SPT | Negative (<0.4) | 1.01 (0.46–2.48 |
| Median HDM-specific serum IgE (CAPFEIA) | Negative (<0.35 KU/I) | 8.9 (0.39–>100) |
| Median symptom score | Negative (<5) | 18 (9–28) |
| Co-sensitizations (median) | 0 | 3 |
| Birch pollen (%) | 0 | 75 |
| Grass pollen (%) | 0 | 81.25 |
| Cat (%) | 0 | 43.75 |
| Dog (%) | 0 | 56.25 |
| Cohort overlap | 12 | 12 |